(Q39420849)

English

Prospective Evaluation of Transcatheter Arterial Chemoembolization (TACE) with Multiple Anti-Cancer Drugs (Epirubicin, Cisplatin, Mitomycin C, 5-Fluorouracil) Compared with TACE with Epirubicin for Treatment of Hepatocellular Carcinoma

scientific article published on February 23, 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Prospective Evaluation of Transcatheter Arterial Chemoembolization (TACE) with Multiple Anti-Cancer Drugs (Epirubicin, Cisplatin, Mitomycin C, 5-Fluorouracil) Compared with TACE with Epirubicin for Treatment of Hepatocellular Carcinoma (English)

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shinya Sahara

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Nobuyuki Kawai

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Morio Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Takami Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Akira Ikoma

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Kouhei Nakata

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hiroki Sanda

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hiroki Minamiguchi

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Motoki Nakai

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shintaro Shirai

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tetsuo Sonomura

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22358993

25 December 2024

publication date

23 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00270-012-0352-x.pdf

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

http://link.springer.com/article/10.1007/s00270-012-0352-x/fulltext.html

HyperText Markup Language

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

http://link.springer.com/content/pdf/10.1007/s00270-012-0352-x

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

CardioVascular and Interventional Radiology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1363-1371

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0352-X

21 January 2018

Hepatic artery embolization in 120 patients with unresectable hepatoma

4

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer

6

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results

9

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma

15

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

A retrospective comparative study of epirubicin–lipiodol emulsion and cisplatin–lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma

16

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Comparative study of cisplatin and epirubicin in transcatheter arterial chemoembolization for hepatocellular carcinoma

17

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion

18

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study

19

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver

21

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma

24

1 reference

10.1007/S00270-012-0352-X

https://api.crossref.org/works/10.1007/S00270-012-0352-X

25 December 2024

Identifiers

10.1007/S00270-012-0352-X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39420849&oldid=2291300182"